COVID-19 cost 5.5 million years of American life The coronavirus pandemic shortened American lives by a wider degree in 2020 than any cause other than heart disease and cancer, according to a new analysis. Provisional data from the Centers for Disease Control and Prevention, analyzed by the Pew Research Center, found the virus that killed more than 380,000 Americans last year — and more than 600,000 to date — cost nearly 5.5 million years of life that those victims would otherwise have been expected to live. That is more years of lost life than Americans lose to all accidents combined, including traffic accidents, drug overdoses, drownings and firearm deaths. It is about half the 10.2 million years of life that cancer costs Americans in a given year. The measurement of the number of life years lost to any particular cause takes into account the average life expectancy of a victim. Read more here. Biden administration investing billions in antiviral pills for COVID-19 The Biden administration plans to invest billions of dollars in antiviral pills to treat COVID-19 and ready the U.S. to combat future viruses that have the potential to spark a pandemic. Officials committed to spending more than $3 billion on the Antiviral Program for Pandemics that aims to support and speed up the development and production of antiviral treatments for COVID-19 to reduce serious illnesses and deaths. The multiyear funding will help to launch clinical research and manufacturing, and the hope is for some treatments to be available by the end of 2021. The goal of the program is to produce an oral drug that Americans can take early in their COVID-19 infection to prevent hospitalizations and fatalities from the disease. Such an oral pill would operate similarly to antiviral treatments for influenza, HIV and hepatitis C. Read more here. Democratic senators press PhRMA over COVID-19 lobbying efforts Democratic senators are pressing the Pharmaceutical Research and Manufacturers of America (PhRMA) to provide more information about its lobbying efforts amid the pandemic. In a letter to PhRMA CEO Stephen Ubl, Sens. Elizabeth Warren (D-Mass.), Bernie Sanders (I-Vt.), Sheldon Whitehouse (D-R.I.) and Tammy Baldwin (D-Wis.) asked the trade group and its member companies to disclose their lobbying spending to oppose a measure to waive intellectual property projections on COVID-19 vaccines. "While taking credit for the development of new COVID vaccines – which were developed with massive infusions of federal funds - the pharmaceutical industry has not backed off of its efforts to block drug pricing proposals and maintain the status quo," the lawmakers wrote in a letter sent Wednesday. Drugmakers have renewed clout in Washington after successfully manufacturing lifesaving COVID-19 vaccines. But progressives criticized pharmaceutical firms such as Pfizer and Johnson & Johnson for lobbying against a waiver meant to allow lower-income nations to manufacture their own doses. Read more here. |
No comments:
Post a Comment